Nicholas A. Smith

Array ( [id] => 6601514 [patent_doc_number] => 20100322941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Human Anti-IP-10 Antibodies Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/529124 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25054 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322941.pdf [firstpage_image] =>[orig_patent_app_number] => 12529124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33961 [patent_doc_number] => 07786268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Anti-IP-10 antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/072824 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 25056 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786268.pdf [firstpage_image] =>[orig_patent_app_number] => 12072824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960081 [patent_doc_number] => 20080274506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/033642 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 40278 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274506.pdf [firstpage_image] =>[orig_patent_app_number] => 12033642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879266 [patent_doc_number] => 20080152649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'OPTIMIZED IGF-1R ANTIBODIES AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/027694 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 44670 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152649.pdf [firstpage_image] =>[orig_patent_app_number] => 12027694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726701 [patent_doc_number] => 20080206242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'METHOD OF TREATMENT OF TH2-MEDIATED CONDITIONS USING OPTIMIZED ANTI-CD30 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/024317 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 45935 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206242.pdf [firstpage_image] =>[orig_patent_app_number] => 12024317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8213313 [patent_doc_number] => 08192737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Identification and engineering of antibodies with variant Fc regions and methods of using same' [patent_app_type] => utility [patent_app_number] => 12/022772 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 75 [patent_no_of_words] => 79290 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/192/08192737.pdf [firstpage_image] =>[orig_patent_app_number] => 12022772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785015 [patent_doc_number] => 20080138344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 12/022762 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 79083 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138344.pdf [firstpage_image] =>[orig_patent_app_number] => 12022762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458268 [patent_doc_number] => 20090258420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Altered polypeptides, immunoconjugates thereof, and methods related thereto' [patent_app_type] => utility [patent_app_number] => 12/012224 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 59217 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258420.pdf [firstpage_image] =>[orig_patent_app_number] => 12012224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844469 [patent_doc_number] => 08946385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Chimeric Fcγ receptor and method for determination of ADCC activity by using the receptor' [patent_app_type] => utility [patent_app_number] => 12/525031 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11805 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12525031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7730125 [patent_doc_number] => 08101720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Immunoglobulin insertions, deletions and substitutions' [patent_app_type] => utility [patent_app_number] => 12/020443 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 35 [patent_no_of_words] => 41475 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101720.pdf [firstpage_image] =>[orig_patent_app_number] => 12020443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872737 [patent_doc_number] => 20080199471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'OPTIMIZED CD40 ANTIBODIES AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/018754 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 46672 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199471.pdf [firstpage_image] =>[orig_patent_app_number] => 12018754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501694 [patent_doc_number] => 20090162382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'OPTIMIZED CA9 ANTIBODIES AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/016884 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 43737 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162382.pdf [firstpage_image] =>[orig_patent_app_number] => 12016884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096205 [patent_doc_number] => 20110003336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Methods for Increasing the Therapeutic Efficacy of Immunoglobulin G Class 3 (IgG3) Antibodies' [patent_app_type] => utility [patent_app_number] => 12/809981 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6144 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003336.pdf [firstpage_image] =>[orig_patent_app_number] => 12809981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675637 [patent_doc_number] => 20080213266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Method for Treating CCR4-Related Diseases' [patent_app_type] => utility [patent_app_number] => 11/969555 [patent_app_country] => US [patent_app_date] => 2008-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 38436 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213266.pdf [firstpage_image] =>[orig_patent_app_number] => 11969555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872723 [patent_doc_number] => 20080199457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Anti-CD63 antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/005224 [patent_app_country] => US [patent_app_date] => 2007-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12373 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199457.pdf [firstpage_image] =>[orig_patent_app_number] => 12005224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9971235 [patent_doc_number] => 09018245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Method for promoting immune response comprising inhibiting CD22 function in B cells' [patent_app_type] => utility [patent_app_number] => 12/516134 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 4 [patent_no_of_words] => 7252 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12516134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245695 [patent_doc_number] => 20100136018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic use' [patent_app_type] => utility [patent_app_number] => 12/448372 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 96227 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136018.pdf [firstpage_image] =>[orig_patent_app_number] => 12448372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954523 [patent_doc_number] => 20080187547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'IRTA-5 ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 11/958683 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30001 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187547.pdf [firstpage_image] =>[orig_patent_app_number] => 11958683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555663 [patent_doc_number] => 08067564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Methods of obtaining a specific binding member that binds eotaxin' [patent_app_type] => utility [patent_app_number] => 11/958210 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20346 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067564.pdf [firstpage_image] =>[orig_patent_app_number] => 11958210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440667 [patent_doc_number] => 20100104509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'HUMAN ANTIBODIES THAT BIND CD19 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/519149 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 68803 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104509.pdf [firstpage_image] =>[orig_patent_app_number] => 12519149 [rel_patent_id] =>[rel_patent_doc_number] =>)